Lavipharm SA · LSX:A3DSHM

Lavipharm SA financial statements

Lavipharm SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue62.6M52.9M50.9M39.1M39.7M37.6M33.6M31.8M31.6M32.0M
Cost of revenue33.8M29.2M27.7M22.7M25.0M22.5M18.6M17.0M17.3M17.5M
Gross profit28.8M23.7M23.2M16.4M14.7M15.1M14.9M14.7M14.2M14.6M
Research and development344.0K285.0K195.0K365.0K812.0K753.0K290.0K410.0K299.0K249.0K
Selling, general and administrative2.85M2.46M2.62M2.33M2.49M2.67M13.8M15.1M15.0M17.5M
Operating income7.16M4.26M4.18M2.69M-398.0K1.96M876.0K-370.0K1.19M-2.63M
Depreciation and amortization5.21M4.58M4.21M1.71M1.65M1.57M1.42M1.18M2.21M3.45M
EBITDA12.4M8.84M8.39M4.39M1.25M3.53M2.30M814.0K3.40M820.0K
Interest expense1.84M2.09M2.27M1.64M1.83M1.92M1.93M1.93M1.99M4.60M
Income before tax7.50M3.60M3.25M2.26M2.75M3.31M2.12M2.86M12.9M11.7M
Income tax2.45M-5.06M1.25M1.31M1.02M1.21M-3.21M1.61M-37.0K2.81M
Net income5.99M8.98M1.87M834.0K1.72M2.09M5.33M1.25M12.9M3.66M
Earnings per share, basic0.040.050.010.040.090.110.290.070.710.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents6.11M5.59M8.44M18.2M1.64M1.93M1.73M1.84M2.35M1.68M
Short-term investments3.00K1.00K12.0K44.0K
Receivables22.6M16.1M21.7M15.4M14.5M9.88M12.5M11.6M11.3M13.1M
Inventory23.2M20.8M14.8M10.9M9.59M8.42M6.49M4.90M5.76M6.29M
Current assets53.2M45.0M45.7M45.6M26.0M23.3M20.7M18.6M19.9M21.3M
Property, plant and equipment17.1M17.6M17.0M17.2M15.3M15.3M18.6M
Total assets130.7M125.7M114.8M114.3M53.0M50.6M49.9M41.9M44.9M48.7M
Accounts payable9.75M8.32M9.96M7.77M6.36M2.74M6.03M4.43M3.75M3.94M
Current liabilities44.0M39.1M35.8M45.7M23.2M18.8M17.4M14.7M19.5M41.9M
Long-term debt10.2M12.2M12.7M3.96M4.00M24.0M25.7M26.7M39.8M56.8M
Total debt28.4M33.8M32.4M37.1M37.3M36.3M40.7M40.5M41.5M79.1M
Total liabilities74.3M72.7M72.1M74.0M62.9M62.9M64.3M61.4M64.8M105.6M
Shareholders' equity56.4M53.0M42.7M40.3M-9.98M-12.3M-14.4M-19.5M-19.9M-31.8M
Shares outstanding169.2M168.5M168.2M21.5M18.3M18.3M18.3M18.3M18.3M18.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations6.72M4.80M539.0K3.37M3.84M2.85M2.90M1.43M1.54M622.0K
Capital spending-4.62M-9.64M-4.12M-35.6M-1.92M-1.48M-2.42M-1.03M-350.0K-97.0K
Free cash flow2.10M-4.85M-3.58M-32.2M1.92M1.38M483.0K398.0K1.19M525.0K
Cash from investing-993.0K-9.66M-3.71M-35.6M-1.91M-1.48M-2.41M-1.03M250.0K418.0K
Cash from financing-5.35M2.16M-6.63M48.8M-2.23M-1.18M-595.0K-904.0K-1.11M97.0K
Dividends paid-3.38M
Share buybacks-200.0K0-2.50M49.3M
Change in cash517.0K-2.85M-9.81M16.6M-294.0K200.0K-110.0K-506.0K673.0K1.14M